THEUER CHARLES 4
4 · Tracon Pharmaceuticals, Inc. · Filed Nov 22, 2022
Insider Transaction Report
Form 4
THEUER CHARLES
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-11-18$1.41/sh+13,900$19,599→ 310,118 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.3992 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.